Literature DB >> 15939235

Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.

Ken-ichi Hosoya1, Vincent H L Lee, Kwang-Jin Kim.   

Abstract

Conjunctiva plays many roles including protection of ocular surface, production of tear film, and a conduit for drug clearance (depending on drug properties) into the systemic circulation or for drug transport to the deep tissues of the eye. The conjunctiva, which is a moderately tight epithelium, endowed with various transport processes for the homeostasis of ions, solutes, and water in the conjunctival surface and tear film. Modulation of ion transport in the conjunctiva leads to alterations in transconjunctival fluid flow that may become useful for treatment of dry-eye state in the eye. As a possible drug delivery route to the posterior portion of the eye, conjunctiva is an attractive route due to both larger surface area than that of cornea and expression of several key transport processes. Tear contains D-glucose and many amino acids, in addition to the usual ions in the body fluids. Several ion-coupled solute transport processes for absorption of amino acids, D-glucose, monocarboxylate, nucleosides, and dipeptides are expressed in the conjunctiva. Thanks to the rich endowment of these transport processes, drug transport across the conjunctiva into the intraocular tissues may become quite feasible. Subconjunctival injection of microparticles and matrix materials (which allows sustained release of drugs) is shown to maintain reasonable levels of various drugs in the vitreous, perhaps attesting to the fact that conjunctiva per se may contribute as a part of multiple transport barrier(s) in ocular drug delivery. In addition, several conjunctival approaches have been investigated to optimize treatment of dry-eye syndrome and intraocular diseases, and more can be accomplished in the coming years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939235     DOI: 10.1016/j.ejpb.2004.12.007

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  19 in total

1.  Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability.

Authors:  Jay M Stewart; On-Tat Lee; Fergus F Wong; David S Schultz; Ricardo Lamy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

2.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

Review 3.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

Review 4.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 5.  Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.

Authors:  Olivia L Lanier; Miranda G Manfre; Claire Bailey; Zhen Liu; Zachary Sparks; Sandesh Kulkarni; Anuj Chauhan
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

6.  Effect of menthol on ocular drug delivery.

Authors:  Xiaolin Xu; Nannan Yu; Zhengzhong Bai; Yanbin Xun; Di Jin; Zhijian Li; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-20       Impact factor: 3.117

Review 7.  Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.

Authors:  Yaru Wang; Changhong Wang
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

8.  Functional identification of a novel transport system for endogenous and synthetic opioid peptides in the rabbit conjunctival epithelial cell line CJVE.

Authors:  Sudha Ananth; Senthil Karunakaran; Pamela M Martin; Chandrasekharam N Nagineni; John J Hooks; Sylvia B Smith; Puttur D Prasad; Vadivel Ganapathy
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

Review 9.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

10.  Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye.

Authors:  Silvia Pescina; Fabio Sonvico; Adryana Clementino; Cristina Padula; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.